Medical Center Hera EOOD

Research site

Bulgaria Ulitsa Tsar Boris Treti 11a, Fl 2, 3400 Montana, Bulgaria

7 trials recruiting
Asthma · Myasthenia gravis · Respiratory syncytial virus infection
Adults and children

About Specializations

Medical Center Hera EOOD in Montana, Bulgaria specialises in clinical trials of conditions such as Asthma, Myasthenia gravis, Respiratory syncytial virus infection, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Ulitsa Tsar Boris Treti 11a, Fl 23400 MontanaBulgaria

Open in maps ↗

Recruiting now: 7 trials
Conditions studied: 12

More sites in Montana Bulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

19 clinical trials

COVID-19

Recruiting

A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

Investigational

A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Molnupiravir
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Secondary progressive multiple sclerosis

Recruiting

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Remibrutinib
Sponsor:Novartis Pharma AG

Contact Research Centre

Myasthenia gravis

Recruiting

A study of IM-101 in adults with generalized myasthenia gravis or ocular myasthenia gravis

Registered drug

A study of IM-101 in adults with generalized myasthenia gravis or ocular myasthenia gravis

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:IM-101
Sponsor:Immunabs Inc.

Contact Research Centre

Myasthenia gravis

Recruiting

Study of oral cladribine compared to placebo for patients with generalized myasthenia gravis

Registered drug

Study of oral cladribine compared to placebo for patients with generalized myasthenia gravis

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Cladribine
Sponsor:Merck Healthcare KGaA

Contact Research Centre

Respiratory syncytial virus infection

Recruiting

A Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease

Investigational

A Study of S-337395 for Adults Not in Hospital with Respiratory Syncytial Virus Who Are at High Risk of Severe Disease

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Sponsor:Shionogi B.V.

Contact Research Centre

Chronic obstructive pulmonary disease

Recruiting

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Depemokimab
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

IgA nephropathy

Recruiting

Study of felzartamab compared to placebo in adults with IgA nephropathy

Registered drug

Study of felzartamab compared to placebo in adults with IgA nephropathy

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Codeine Phosphate
Sponsor:Biogen Idec Research Limited

Contact Research Centre

Obesity

Not yet recruiting

KAI-9531 in Adults With Obesity or Overweight and Diabetes

Investigational

KAI-9531 in Adults With Obesity or Overweight and Diabetes

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:HRS 9531

Contact Research Centre

Asthma

Not recruiting

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Asthma in Patients Aged 12 and Older

Investigational

Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Asthma in Patients Aged 12 and Older

Investigational

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Salbutamol Sulfate
Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Contact Research Centre

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Atorvastatin
Sponsor:Novartis Pharma AG

Contact Research Centre

Asthma

Not recruiting

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Atuliflapon
Sponsor:AstraZeneca AB

Contact Research Centre

Obesity

Not recruiting

Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes

Registered drug

Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:HRS 9531

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites